Predictive nomogram integrating radiomics and multi-omics for improved prognosis-model in cholangiocarcinoma

Yunlu Jia; Mingyu Wan; Yifei Shen; Junli Wang; Xiao Luo; Mengye He; Ruiliang Bai; Wenbo Xiao; Xiaochen Zhang; Jian Ruan

doi:10.1002/ctm2.70171

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (1) : e70171 DOI: 10.1002/ctm2.70171

LETTER TO THE JOURNAL

Predictive nomogram integrating radiomics and multi-omics for improved prognosis-model in cholangiocarcinoma

Author information +

History +

PDF

Cite this article

Download citation ▾

Yunlu Jia, Mingyu Wan, Yifei Shen, Junli Wang, Xiao Luo, Mengye He, Ruiliang Bai, Wenbo Xiao, Xiaochen Zhang, Jian Ruan. Predictive nomogram integrating radiomics and multi-omics for improved prognosis-model in cholangiocarcinoma. Clinical and Translational Medicine, 2025, 15(1): e70171 DOI:10.1002/ctm2.70171

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Zhang L, Cai JQ, Zhao JJ, et al. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2010;101(3):233-238.

[2]	Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563-577.

[3]	van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104-e107.

[4]	Ma B, Meng H, Tian Y, et al. Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma. BMC Cancer. 2020;20:1-12.

[5]	Shibahara H, Tamada S, Higashi M, et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 2004;39(1):220-229.

[6]	Sha D, Jin Z, Budczies J, et al. Tumor mutational burden as a predictive biomarker in solid tumors. Cancer Discov. 2020;10(12):1808-1825.

[7]	Zou S, Li J, Zhou H, et al. Mutational landscape of intrahepatic cholangiocarcinoma. Nat Commun. 2014;5(1):5696.

[8]	Lamontagne RJ, Casciano JC, Bouchard MJ. A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways. Metabolism. 2018;83:50-59.

[9]	Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;298(3):505-516. Epub 2021 Jan 5.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.